In the first case, an internal investigation did not find any product quality issues, according to Empowers investigation report, obtained via an open records request
The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing
Target: 5 mg once daily or 2.5 mg twice daily (BID)
8,396,600 warrants outstanding from prior financings Insider buying of CAD $40,725 A subscription for approximately 33.6% of the offering by Emerging Markets Consulting, the Companys compensated investor relations firm A commitment not to sell while serving as the Companys Investor Relations firm, terminable by EMC at its own discretion We encourage investors to conduct their own due diligence, review the Companys public filings on SEDAR+ at sedarplus.ca and on otcmarkets.com, and determine whether an investment in the Company is suitable for them
Most recommendations emphasize conservative dosage , timed cycles, and professional oversight